Novel androgen receptor antagonist-mediated chemoprevention of prostate cancer
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $596,209
Award facts
- Opportunity
-
- NO1CN500347 Solicitation number
- Contract value 100% obligated
- $596,209.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | -$2,374 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $598,583 |
About this award
This federal contract award from the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, is for a $596,209 Firm Fixed Price Delivery Order under the "PREVENT Cancer Program (PREVENT)" contract vehicle. The contract is for the "NOVEL ANDROGEN RECEPTOR ANTAGONIST-MEDIATED CHEMOPREVENTION OF PROSTATE CANCER" project, which aims to conduct preclinical research to support the development of therapies for prostate cancer prevention. IITRI, a non-profit contract research organization, will leverage its expertise in preclinical drug development services to perform pharmacology, toxicology, safety, and efficacy evaluations of potential treatments. This task order is not associated with any set-aside designation. The parent organization, Illinois Institute of Technology, has been awarded numerous contracts and grants from federal agencies like the National Institutes of Health to advance various biomedical and engineering research initiatives.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100002 worth?
The government has obligated $596,209 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201500042I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award